Research Focus

Former Employee. NONDIVISIONAL COST; Conversion Jobcode

Recent additions – View all

1. Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas

   Journal Article

   Casper, E. S.; Green, M. R.; Kelsen, D. P.; Heelan, R. T.; Brown, T. D.; Flombaum, C. D.; Trochanowski, B.; Tarassoff, P. G.
   Investigational New Drugs (1994)

   Fulltext@MSK | Save
2. Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor

   Journal Article

   Saltz, L.; Sirott, M.; Young, C.; Tong, W.; Niedzwiecki, D.; Tzy-Jyun, Y.; Tao, Y.; Trochanowski, B.; Wright, P.; Barbosa, K.; more...
   JNCI: Journal of the National Cancer Institute (1993)

   Fulltext@MSK | Save
3. Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer

   Journal Article

   Atiq, O. T.; Kelsen, D. P.; Shiu, M. H.; Saltz, L.; Tong, W.; Niedzwiecki, D.; Trochanowski, B.; Lin, S.; Toomasi, F.; Brennan, M.
   Journal of Clinical Oncology (1993)

   Fulltext@MSK | Save